Found 226 matching trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents PHASE2 The purpose of the study was to evaluate the immunogenicity and describe th...
Show More Location
Multiple Locations
Treatments Being Tested
Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine Meningococcal (Groups A, C, Y and W135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed GARDASIL®: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed GARDASIL®: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant Learn More & Join Trial
Gardasil Versus Cervarix in the Treatment of Warts PHASE3 Warts are common, benign, epidermal proliferations caused by HPV infecting ...
Show More Location
Dermatology department, Zagazig University Hospitals, Faculty of Medicine, Zagazig University
Learn More & Join Trial
Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009) PHASE3 Primary objective:
• To demonstrate that administration of V503 induces no...
Show More Location
Multiple Locations
Learn More & Join Trial
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease PHASE4 The Gardasil vaccine, a vaccine targeted towards the human papillomavirus (...
Show More Learn More & Join Trial
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China PHASE3 The study is to evaluate immune response induced by 9-valent HPV study vacc...
Show More Status
Active Not Recruiting
Location
Yunnan Center for Disease Prevention and Control
Learn More & Join Trial
Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents PHASE3 Primary Objective:
To demonstrate the non-inferiority of the seroprotectio...
Show More Location
Investigational Site Number :3480003
Learn More & Join Trial
Immunogenicity and Safety of One Dose of HPV Vaccine PHASE4 This study will assess the immunogenicity and safety of one dose of Cecolin...
Show More Location
Fujian Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico PHASE4 In September 2009 the National Vaccination Council approved the policy for ...
Show More Location
Centro Médico Cuauhtemoc
Learn More & Join Trial
Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064) PHASE3 The purposes of this phase 3, double-blind, placebo-controlled clinical stu...
Show More Location
Umeyama Clinic ( Site 6406)
Learn More & Join Trial
Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination PHASE3 A research project is currently being undertaken looking at Human Papilloma...
Show More Location
Royal Childrens Hospital
Learn More & Join Trial